1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	711_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	711_QUEST_clinical_caseMIR	SENT1	-	-
3	26	26		-	-	9-11	711_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	711_QUEST_clinical_caseMIR	SENT1	-	-
5	que	que	PR0CN000	-	-	17-20	711_QUEST_clinical_caseMIR	SENT1	-	-
6	consulta	consultar	VMM02S0	C1704447_1	calificador_1	21-29	711_QUEST_clinical_caseMIR	SENT1	-	-
7	por	por	SPS00	C1704447_2	calificador_2	30-33	711_QUEST_clinical_caseMIR	SENT1	-	-
8	sensación	sensación	NCFS000	C0036658#C1455667	calificador	34-43	711_QUEST_clinical_caseMIR	SENT1	-	-
9	de	de	SPS00	C0332285	atributo	44-46	711_QUEST_clinical_caseMIR	SENT1	-	-
10	debilidad	debilidad	NCFS000	C0424594#C0004093#C3714552	hallazgo	47-56	711_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
11	generalizada	generalizar	VMP00SF	-	-	57-69	711_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
12	que	que	PR0CN000	-	-	70-73	711_QUEST_clinical_caseMIR	SENT1	-	-
13	se	se	P00CN000	-	-	74-76	711_QUEST_clinical_caseMIR	SENT1	-	-
14	ha	haber	VAIP3S0	-	-	77-79	711_QUEST_clinical_caseMIR	SENT1	-	-
15	instaurado	instaurar	VMP00SM	-	-	80-90	711_QUEST_clinical_caseMIR	SENT1	-	-
16	progresivamente	progresivamente	RG	-	-	91-106	711_QUEST_clinical_caseMIR	SENT1	-	-
17	en	en	SPS00	C1720294#C0332285	calificador#atributo	107-109	711_QUEST_clinical_caseMIR	SENT1	-	-
18	el	el	DA0MS0	-	-	110-112	711_QUEST_clinical_caseMIR	SENT1	-	-
19	curso	curso	NCMS000	C0750729	atributo#calificador	113-118	711_QUEST_clinical_caseMIR	SENT1	-	-
20	de	de	SPS00	C0332285	atributo	119-121	711_QUEST_clinical_caseMIR	SENT1	-	-
21	tres	tres		-	-	122-126	711_QUEST_clinical_caseMIR	SENT1	-	-
22	semanas	semana	NCFP000	C0439230	calificador	127-134	711_QUEST_clinical_caseMIR	SENT1	-	-
23	,	,	Fc	-	-	134-135	711_QUEST_clinical_caseMIR	SENT1	-	-
24	haciendo	hacer	VMG0000	-	-	136-144	711_QUEST_clinical_caseMIR	SENT1	-	-
25	se	se	PP3CN000	-	-	144-146	711_QUEST_clinical_caseMIR	SENT1	-	-
26	especialmente	especialmente	RG	-	-	147-160	711_QUEST_clinical_caseMIR	SENT1	-	-
27	intensa	intenso	AQ0FS0	C0205178	calificador	161-168	711_QUEST_clinical_caseMIR	SENT1	-	-
28	en	en	SPS00	C1720294#C0332285	calificador#atributo	169-171	711_QUEST_clinical_caseMIR	SENT1	-	-
29	los	el	DA0MP0	-	-	172-175	711_QUEST_clinical_caseMIR	SENT1	-	-
30	últimos	último	AO0MP0	-	-	176-183	711_QUEST_clinical_caseMIR	SENT1	-	-
31	dos	dos		-	-	184-187	711_QUEST_clinical_caseMIR	SENT1	-	-
32	días	día	NCMP000	C0439228#C0332169	calificador	188-192	711_QUEST_clinical_caseMIR	SENT1	-	-
33	.	.	Fp	-	-	192-193	711_QUEST_clinical_caseMIR	SENT1	-	-

1	Refiere	referir	VMIP3S0	-	-	194-201	711_QUEST_clinical_caseMIR	SENT2	-	-
2	desde	desde	SPS00	-	-	202-207	711_QUEST_clinical_caseMIR	SENT2	-	-
3	hace	hacer	VMIP3S0	-	-	208-212	711_QUEST_clinical_caseMIR	SENT2	-	-
4	un	un		C0205447_1	calificador_1	213-215	711_QUEST_clinical_caseMIR	SENT2	-	-
5	par	par	NCMS000	-	-	216-219	711_QUEST_clinical_caseMIR	SENT2	-	-
6	de	de	SPS00	C0332285	atributo	220-222	711_QUEST_clinical_caseMIR	SENT2	-	-
7	años	año	NCMP000	C0439234	calificador	223-227	711_QUEST_clinical_caseMIR	SENT2	-	-
8	episodios	episodio	NCMP000	C0332189	atributo	228-237	711_QUEST_clinical_caseMIR	SENT2	-	-
9	de	de	SPS00	C0332285	atributo	238-240	711_QUEST_clinical_caseMIR	SENT2	-	-
10	dolor	dolor	NCMS000	C0003862_1	hallazgo_1	241-246	711_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
11	articular	articular	VMN0000	C0003862_2	hallazgo_2	247-256	711_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
12	en	en	SPS00	C1720294#C0332285	calificador#atributo	257-259	711_QUEST_clinical_caseMIR	SENT2	-	-
13	las	el	DA0FP0	-	-	260-263	711_QUEST_clinical_caseMIR	SENT2	-	-
14	manos	mano	NCFP000	C3714557#C1281583	estructura_corporal	264-269	711_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
15	que	que	PR0CN000	-	-	270-273	711_QUEST_clinical_caseMIR	SENT2	-	-
16	han	haber	VAIP3P0	-	-	274-277	711_QUEST_clinical_caseMIR	SENT2	-	-
17	precisado	precisar	VMP00SM	-	-	278-287	711_QUEST_clinical_caseMIR	SENT2	-	-
18	de	de	SPS00	C0332285	atributo	288-290	711_QUEST_clinical_caseMIR	SENT2	-	-
19	la	el	DA0FS0	-	-	291-293	711_QUEST_clinical_caseMIR	SENT2	-	-
20	toma	toma	NCFS000	-	-	294-298	711_QUEST_clinical_caseMIR	SENT2	-	-
21	de	de	SPS00	C0332285	atributo	299-301	711_QUEST_clinical_caseMIR	SENT2	-	-
22	antiinflamatorios	antiinflamatorios	NC00AO0	-	-	302-319	711_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
23	,	,	Fc	-	-	319-320	711_QUEST_clinical_caseMIR	SENT2	-	-
24	así	así	RG	-	-	321-324	711_QUEST_clinical_caseMIR	SENT2	-	-
25	como	como	SPS00	C0332257	calificador	325-329	711_QUEST_clinical_caseMIR	SENT2	-	-
26	la	el	DA0FS0	-	-	330-332	711_QUEST_clinical_caseMIR	SENT2	-	-
27	aparición	aparición	NCFS000	-	-	333-342	711_QUEST_clinical_caseMIR	SENT2	-	-
28	de	de	SPS00	C0332285	atributo	343-345	711_QUEST_clinical_caseMIR	SENT2	-	-
29	alguna	alguno	DI0FS0	C0205392	calificador	346-352	711_QUEST_clinical_caseMIR	SENT2	-	-
30	lesión	lesión	NCFS000	C0332447#C1313971#C0221198	anomalía_morfológica	353-359	711_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
31	eritematosa	eritematosa	AQ0FS00	-	-	360-371	711_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
32	de	de	SPS00	C0332285	atributo	372-374	711_QUEST_clinical_caseMIR	SENT2	-	-
33	causa	causa	NCFS000	-	-	375-380	711_QUEST_clinical_caseMIR	SENT2	-	-
34	no	no	RN	C1298908	calificador	381-383	711_QUEST_clinical_caseMIR	SENT2	-	-
35	aclarada	aclarar	VMP00SF	-	-	384-392	711_QUEST_clinical_caseMIR	SENT2	-	-
36	en	en	SPS00	C1720294#C0332285	calificador#atributo	393-395	711_QUEST_clinical_caseMIR	SENT2	-	-
37	la	el	DA0FS0	-	-	396-398	711_QUEST_clinical_caseMIR	SENT2	-	-
38	zona	zona	NCFS000	C0019360	trastorno	399-403	711_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
39	del	del	SP+DA	-	-	404-407	711_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
40	escote	escote	NCMS000	-	-	408-414	711_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
41	,	,	Fc	-	-	414-415	711_QUEST_clinical_caseMIR	SENT2	-	-
42	principalmente	principalmente	RG	-	-	416-430	711_QUEST_clinical_caseMIR	SENT2	-	-
43	en	en	SPS00	C1720294#C0332285	calificador#atributo	431-433	711_QUEST_clinical_caseMIR	SENT2	-	-
44	verano	verano	NCMS000	-	-	434-440	711_QUEST_clinical_caseMIR	SENT2	-	-
45	.	.	Fp	-	-	440-441	711_QUEST_clinical_caseMIR	SENT2	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	442-444	711_QUEST_clinical_caseMIR	SENT3	-	-
2	la	el	DA0FS0	-	-	445-447	711_QUEST_clinical_caseMIR	SENT3	-	-
3	exploración	exploración	NCFS000	C0031809_1	procedimiento_1	448-459	711_QUEST_clinical_caseMIR	SENT3	-	-
4	física	físico	NCFS000	C0031809_2	procedimiento_2	460-466	711_QUEST_clinical_caseMIR	SENT3	-	-
5	destaca	destacar	VMIP3S0	-	-	467-474	711_QUEST_clinical_caseMIR	SENT3	-	-
6	únicamente	únicamente	RG	-	-	475-485	711_QUEST_clinical_caseMIR	SENT3	-	-
7	una	una		C0205447_1	calificador_1	486-489	711_QUEST_clinical_caseMIR	SENT3	-	-
8	palidez	palidez	NCFS000	C0030232#C1275397	hallazgo	490-497	711_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
9	cutáneo-mucosa	cutáneo-mucosa	NCFS000	-	-	498-512	711_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
10	evidente	evidente	AQ0CS0	-	-	513-521	711_QUEST_clinical_caseMIR	SENT3	-	-
11	y	y	CC	C1706368	calificador	522-523	711_QUEST_clinical_caseMIR	SENT3	-	-
12	una	una		C0205447_1	calificador_1	524-527	711_QUEST_clinical_caseMIR	SENT3	-	-
13	frecuencia	frecuencia	NCFS000	C0439603#C0376249	calificador#atributo	528-538	711_QUEST_clinical_caseMIR	SENT3	-	-
14	cardiaca	cardiaco	AQ0FS0	-	-	539-547	711_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
15	de	de	SPS00	C0332285	atributo	548-550	711_QUEST_clinical_caseMIR	SENT3	-	-
16	100	100		-	-	551-554	711_QUEST_clinical_caseMIR	SENT3	-	-
17	lpm	lpm	NC00YL0	-	-	555-558	711_QUEST_clinical_caseMIR	SENT3	-	-
18	.	.	Fp	-	-	558-559	711_QUEST_clinical_caseMIR	SENT3	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	560-562	711_QUEST_clinical_caseMIR	SENT4	-	-
2	el	el	DA0MS0	-	-	563-565	711_QUEST_clinical_caseMIR	SENT4	-	-
3	hemograma	hemograma	NCMS000	C0200631	procedimiento	566-575	711_QUEST_clinical_caseMIR	SENT4	-	-
4	destaca	destacar	VMIP3S0	-	-	576-583	711_QUEST_clinical_caseMIR	SENT4	-	-
5	:	:	Fd	-	-	583-584	711_QUEST_clinical_caseMIR	SENT4	-	-
6	Hb	hb	NC00YL0	-	-	585-587	711_QUEST_clinical_caseMIR	SENT4	-	-
7	6	6	Z	-	-	588-589	711_QUEST_clinical_caseMIR	SENT4	-	-
8	gr	g	NC00SC0	-	-	590-592	711_QUEST_clinical_caseMIR	SENT4	-	-
9	/	/	Fh	-	-	592-593	711_QUEST_clinical_caseMIR	SENT4	-	-
10	dL	decilitro	NCMN000	C0439241	calificador	593-595	711_QUEST_clinical_caseMIR	SENT4	-	-
11	,	,	Fc	-	-	595-596	711_QUEST_clinical_caseMIR	SENT4	-	-
12	Hto	hematócrito	NC00YL0	-	-	597-600	711_QUEST_clinical_caseMIR	SENT4	-	-
13	27	27	Z	-	-	601-603	711_QUEST_clinical_caseMIR	SENT4	-	-
14	%	%	Ft	-	-	604-605	711_QUEST_clinical_caseMIR	SENT4	-	-
15	,	,	Fc	-	-	605-606	711_QUEST_clinical_caseMIR	SENT4	-	-
16	VCM	vcm	NC00SC0	C0524587	entidad_observable	607-610	711_QUEST_clinical_caseMIR	SENT4	-	-
17	105	105		-	-	611-614	711_QUEST_clinical_caseMIR	SENT4	-	-
18	fL	fl	NC00SC0	C0475213	calificador	615-617	711_QUEST_clinical_caseMIR	SENT4	-	-
19	,	,	Fc	-	-	617-618	711_QUEST_clinical_caseMIR	SENT4	-	-
20	3.420	3.420		-	-	619-624	711_QUEST_clinical_caseMIR	SENT4	-	-
21	leucocitos/mm3	leucocitos/mm3		-	-	625-639	711_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
22	(	(	Fpa	-	-	640-641	711_QUEST_clinical_caseMIR	SENT4	-	-
23	2300	2300		-	-	641-645	711_QUEST_clinical_caseMIR	SENT4	-	-
24	neutrófilos/mm3	neutrófilos/mm3		-	-	646-661	711_QUEST_clinical_caseMIR	SENT4	-	-
25	,	,	Fc	-	-	661-662	711_QUEST_clinical_caseMIR	SENT4	-	-
26	800	800		-	-	663-666	711_QUEST_clinical_caseMIR	SENT4	-	-
27	linfocitos/mm3	linfocitos/mm3		-	-	667-681	711_QUEST_clinical_caseMIR	SENT4	-	-
28	,	,	Fc	-	-	681-682	711_QUEST_clinical_caseMIR	SENT4	-	-
29	250	250		-	-	683-686	711_QUEST_clinical_caseMIR	SENT4	-	-
30	monocitos/mm3	monocitos/mm3		-	-	687-700	711_QUEST_clinical_caseMIR	SENT4	-	-
31	,	,	Fc	-	-	700-701	711_QUEST_clinical_caseMIR	SENT4	-	-
32	50	50		-	-	702-704	711_QUEST_clinical_caseMIR	SENT4	-	-
33	eosinófilos/mm3	eosinófilos/mm3		-	-	705-720	711_QUEST_clinical_caseMIR	SENT4	-	-
34	,	,	Fc	-	-	720-721	711_QUEST_clinical_caseMIR	SENT4	-	-
35	20	20		-	-	722-724	711_QUEST_clinical_caseMIR	SENT4	-	-
36	basófilos/mm3	basófilos/mm3		-	-	725-738	711_QUEST_clinical_caseMIR	SENT4	-	-
37	)	)	Fpt	-	-	738-739	711_QUEST_clinical_caseMIR	SENT4	-	-
38	,	,	Fc	-	-	739-740	711_QUEST_clinical_caseMIR	SENT4	-	-
39	plaquetas	plaqueta	NCFP000	C0005821	estructura_corporal	741-750	711_QUEST_clinical_caseMIR	SENT4	-	-
40	170.000/mm3	170.000/mm3		-	-	751-762	711_QUEST_clinical_caseMIR	SENT4	-	-
41	.	.	Fp	-	-	762-763	711_QUEST_clinical_caseMIR	SENT4	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	764-766	711_QUEST_clinical_caseMIR	SENT5	-	-
2	la	el	DA0FS0	-	-	767-769	711_QUEST_clinical_caseMIR	SENT5	-	-
3	bioquímica	bioquímico	NCFS000	C0205474#C0175854	calificador#ocupación	770-780	711_QUEST_clinical_caseMIR	SENT5	-	-
4	:	:	Fd	-	-	780-781	711_QUEST_clinical_caseMIR	SENT5	-	-
5	AST	aspartato_transaminasa	NC00YL0	-	-	782-785	711_QUEST_clinical_caseMIR	SENT5	-	-
6	30	30		-	-	786-788	711_QUEST_clinical_caseMIR	SENT5	-	-
7	UI	ui	NC00SC0	C0439453	calificador	789-791	711_QUEST_clinical_caseMIR	SENT5	-	-
8	/	/	Fh	-	-	791-792	711_QUEST_clinical_caseMIR	SENT5	-	-
9	L	l	NCFS000	-	-	792-793	711_QUEST_clinical_caseMIR	SENT5	-	-
10	,	,	Fc	-	-	793-794	711_QUEST_clinical_caseMIR	SENT5	-	-
11	ALT	alanina_aminotransferasa_(o_tgp)	NC00YL0	-	-	795-798	711_QUEST_clinical_caseMIR	SENT5	-	-
12	35	35		-	-	799-801	711_QUEST_clinical_caseMIR	SENT5	-	-
13	UI	ui	NC00SC0	C0439453	calificador	802-804	711_QUEST_clinical_caseMIR	SENT5	-	-
14	/	/	Fh	-	-	804-805	711_QUEST_clinical_caseMIR	SENT5	-	-
15	L	l	NCFS000	-	-	805-806	711_QUEST_clinical_caseMIR	SENT5	-	-
16	,	,	Fc	-	-	806-807	711_QUEST_clinical_caseMIR	SENT5	-	-
17	GGT	gammaglutamiltranspeptidasa	NC00YL0	-	-	808-811	711_QUEST_clinical_caseMIR	SENT5	-	-
18	59	59		-	-	812-814	711_QUEST_clinical_caseMIR	SENT5	-	-
19	UI	ui	NC00SC0	C0439453	calificador	815-817	711_QUEST_clinical_caseMIR	SENT5	-	-
20	/	/	Fh	-	-	817-818	711_QUEST_clinical_caseMIR	SENT5	-	-
21	L	l	NCFS000	-	-	818-819	711_QUEST_clinical_caseMIR	SENT5	-	-
22	,	,	Fc	-	-	819-820	711_QUEST_clinical_caseMIR	SENT5	-	-
23	fosfatasa	fosfatasa	NCFS000	C0002059_1	sustancia_1	821-830	711_QUEST_clinical_caseMIR	SENT5	-	-
24	alcalina	alcalino	AQ0FS0	C0002059_2	sustancia_2	831-839	711_QUEST_clinical_caseMIR	SENT5	-	-
25	105	105		-	-	840-843	711_QUEST_clinical_caseMIR	SENT5	-	-
26	UI	ui	NC00SC0	C0439453	calificador	844-846	711_QUEST_clinical_caseMIR	SENT5	-	-
27	/	/	Fh	-	-	846-847	711_QUEST_clinical_caseMIR	SENT5	-	-
28	L	l	NCFS000	-	-	847-848	711_QUEST_clinical_caseMIR	SENT5	-	-
29	,	,	Fc	-	-	848-849	711_QUEST_clinical_caseMIR	SENT5	-	-
30	LDH	ldh	NC00SC0	C0022917	sustancia	850-853	711_QUEST_clinical_caseMIR	SENT5	-	-
31	490	490		-	-	854-857	711_QUEST_clinical_caseMIR	SENT5	-	-
32	UI	ui	NC00SC0	C0439453	calificador	858-860	711_QUEST_clinical_caseMIR	SENT5	-	-
33	/	/	Fh	-	-	860-861	711_QUEST_clinical_caseMIR	SENT5	-	-
34	L	l	NCFS000	-	-	861-862	711_QUEST_clinical_caseMIR	SENT5	-	-
35	,	,	Fc	-	-	862-863	711_QUEST_clinical_caseMIR	SENT5	-	-
36	urea	urea	NCFS000	C0041942	sustancia	864-868	711_QUEST_clinical_caseMIR	SENT5	-	-
37	20	20	Z	-	-	869-871	711_QUEST_clinical_caseMIR	SENT5	-	-
38	mg	mg	NCMN000	-	-	872-874	711_QUEST_clinical_caseMIR	SENT5	-	-
39	/	/	Fh	-	-	874-875	711_QUEST_clinical_caseMIR	SENT5	-	-
40	dL	decilitro	NCMN000	C0439241	calificador	875-877	711_QUEST_clinical_caseMIR	SENT5	-	-
41	,	,	Fc	-	-	877-878	711_QUEST_clinical_caseMIR	SENT5	-	-
42	creatinina	creatinina	NC00SC0	C0010294	sustancia	879-889	711_QUEST_clinical_caseMIR	SENT5	-	-
43	0,8	0.8	Z	-	-	890-893	711_QUEST_clinical_caseMIR	SENT5	-	-
44	mg	mg	NCMN000	-	-	894-896	711_QUEST_clinical_caseMIR	SENT5	-	-
45	/	/	Fh	-	-	896-897	711_QUEST_clinical_caseMIR	SENT5	-	-
46	dL	decilitro	NCMN000	C0439241	calificador	897-899	711_QUEST_clinical_caseMIR	SENT5	-	-
47	.	.	Fp	-	-	899-900	711_QUEST_clinical_caseMIR	SENT5	-	-

1	Teniendo	tener	VMG0000	-	-	901-909	711_QUEST_clinical_caseMIR	SENT6	-	-
2	en	en	SPS00	C1720294#C0332285	calificador#atributo	910-912	711_QUEST_clinical_caseMIR	SENT6	-	-
3	cuenta	cuenta	NCFS000	-	-	913-919	711_QUEST_clinical_caseMIR	SENT6	-	-
4	la	el	DA0FS0	-	-	920-922	711_QUEST_clinical_caseMIR	SENT6	-	-
5	información	información	NCFS000	-	-	923-934	711_QUEST_clinical_caseMIR	SENT6	-	-
6	disponible	disponible	AQ0CS0	C0470187	calificador	935-945	711_QUEST_clinical_caseMIR	SENT6	-	-
7	,	,	Fc	-	-	945-946	711_QUEST_clinical_caseMIR	SENT6	-	-
8	indique	indicar	VMM03S0	-	-	947-954	711_QUEST_clinical_caseMIR	SENT6	-	-
9	cuál	cuál	PT0CS000	-	-	955-959	711_QUEST_clinical_caseMIR	SENT6	-	-
10	de	de	SPS00	C0332285	atributo	960-962	711_QUEST_clinical_caseMIR	SENT6	-	-
11	los	el	DA0MP0	-	-	963-966	711_QUEST_clinical_caseMIR	SENT6	-	-
12	siguientes	siguiente	AQ0CP0	C0332282	atributo	967-977	711_QUEST_clinical_caseMIR	SENT6	-	-
13	parámetros	parámetro	NCMP000	C0549193	atributo	978-988	711_QUEST_clinical_caseMIR	SENT6	-	-
14	analíticos	analítico	AQ0MP0	-	-	989-999	711_QUEST_clinical_caseMIR	SENT6	-	-
15	adicionales	adicional	AQ0CP0	-	-	1000-1011	711_QUEST_clinical_caseMIR	SENT6	-	-
16	necesitaría	necesitar	VMIC3S0	-	-	1012-1023	711_QUEST_clinical_caseMIR	SENT6	-	-
17	conocer	conocer	VMN0000	-	-	1024-1031	711_QUEST_clinical_caseMIR	SENT6	-	-
18	para	para	SPS00	C0521125	calificador	1032-1036	711_QUEST_clinical_caseMIR	SENT6	-	-
19	poder	poder	VMN0000	-	-	1037-1042	711_QUEST_clinical_caseMIR	SENT6	-	-
20	tomar	tomar	VMN0000	C1515187	calificador	1043-1048	711_QUEST_clinical_caseMIR	SENT6	-	-
21	la	el	DA0FS0	-	-	1049-1051	711_QUEST_clinical_caseMIR	SENT6	-	-
22	decisión	decisión	NCFS000	-	-	1052-1060	711_QUEST_clinical_caseMIR	SENT6	-	-
23	inmediata	inmediato	AQ0FS0	C0205253	calificador	1061-1070	711_QUEST_clinical_caseMIR	SENT6	-	-
24	más	más	RG	C0205172	calificador	1071-1074	711_QUEST_clinical_caseMIR	SENT6	-	-
25	apropiada	apropiar	VMP00SF	-	-	1075-1084	711_QUEST_clinical_caseMIR	SENT6	-	-
26	:	:	Fd	-	-	1084-1085	711_QUEST_clinical_caseMIR	SENT6	-	-
27	.	.	Fp	-	-	1085-1086	711_QUEST_clinical_caseMIR	SENT6	-	-

